Michael Andersson
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies 34
- Oncology top 0.5%
- Cancer Treatment and Pharmacology 31
- HER2/EGFR in Cancer Research 30
- Cancer Risks and Factors 15
- Global Cancer Incidence and Screening 7
- Pathology and Forensic Medicine top 0.5%
- Radiation top 1%
-
- Monoclonal and Polyclonal Antibodies Research 11
- Radiation Dose and Imaging 8
-
- Advanced Breast Cancer Therapies 7
- Co-authors
- Hans H. StormEero PukkalaLois B. TravisCharles F. LynchEric J. HolowatyMary GospodarowiczMaj‐Britt JensenClaus Kamby
- Journals
- Journal of Clinical Oncology (17 papers)JNCI Journal of the National Cancer Institute (10 papers)European Journal of Cancer (9 papers)
- Partner nations
- DenmarkSwedenUnited States
In The Last Decade
Michael Andersson
121 papers receiving 7.4k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Cancer Research 2.2k
- Oncology 3.2k
- Pathology and Forensic Medicine 1.6k
- Radiation 505
- Radiology, Nuclear Medicine and Imaging 1.3k
Countries citing papers authored by Michael Andersson
This map shows the geographic impact of Michael Andersson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Andersson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Andersson more than expected).
Fields of papers citing papers by Michael Andersson
This network shows the impact of papers produced by Michael Andersson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Andersson. The network helps show where Michael Andersson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Andersson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2021 | 1 | |
| 3 | 2020 | 14 | |
| 4 | 2020 | 13 | |
| 5 | Medical Entity Corpus with PICO elements and Sentiment Analysis | 2018 | 3 |
| 6 | 2017 | 50 | |
| 7 | 2017 | 106 | |
| 8 | 2015 | 3 | |
| 9 | 2012 | 17 | |
| 10 | 2011 | 141 | |
| 11 | 2011 | 106 | |
| 12 | 2007 | 249 | |
| 13 | Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivorsbreakdown → | 2005 | 560 |
| 14 | 2003 | 457 | |
| 15 | 2003 | 42 | |
| 16 | 2003 | 157 | |
| 17 | 2001 | 14 | |
| 18 | Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trialbreakdown → | 1999 | 1203 |
| 19 | 1999 | 22 | |
| 20 | 1990 | 28 |
About Michael Andersson
Michael Andersson is a scholar working on Oncology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 123 papers that have together received 7.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (34 papers), Cancer Treatment and Pharmacology (31 papers), HER2/EGFR in Cancer Research (30 papers), Cancer Risks and Factors (15 papers), Monoclonal and Polyclonal Antibodies Research (11 papers), Radiation Dose and Imaging (8 papers), Advanced Breast Cancer Therapies (7 papers) and Global Cancer Incidence and Screening (7 papers). The work is most often cited by research in Cancer Research (2.2k citations), Oncology (3.2k citations) and Pathology and Forensic Medicine (1.6k citations). Michael Andersson has collaborated with scholars based in Denmark, Sweden and United States. Frequent co-authors include Hans H. Storm, Eero Pukkala, Lois B. Travis, Charles F. Lynch, Eric J. Holowaty, Mary Gospodarowicz, Maj‐Britt Jensen, Claus Kamby, Per Hall and John D. Boice. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute, European Journal of Cancer, Acta Oncologica and Radiation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.